IL PORTALE per la RICERCA dei DIPARTIMENTI

M. Zampieri, T. Guastafierro, R. Calabrese, F. Ciccarone, A. Reale, P. Caiafa (2011) "ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites"

L. Amicone, C. Cicchini, A. Conigliaro, A. Marchetti, M. Tripodi (2011) "Dynamic behaviour of hepatocyte is orchestrated by dynamic enrolment of HNF4-dependent activator and/or repressor complexes"

FERRAGUTI G., LUCARELLI M. (2011) "Genetic alterations of innate immune response on IBD: planning and setting up a polymorphisms analysis method by multiple PCR and minisequencing"

A.M. Testi (2011) "Long-term use of anagrelide in children and adolescents with Philadelphia-negative myeloprolipherative diseases. 16th Congress of the EHA, London 9-12, 2011, Haematologica Vol 96 (s2), June 2011, abs 0925, p 386."

Ciccarone F, Calabrese R., Zampieri M., Caiafa P (2011) "Poly(ADP-ribosyl)ation reactions are involved in the DNA demethylation process of mouse primordial germ cells"

Testi AM (2011) "Safety and toxicity of intrathecal liposomal cytarabine for treating central nervous system (CNS) relapse in pediatric acute leukemia: a multicenter retrospective study"

A. CAFOLLA (2011) "Study of the Vitamin K Cyclic Metabolism in absence and presence of coumarin anticoagulants by Liquid Chromatography- Linear Ion Trap Mass Spectrometry"

I Del Giudice (2011) "13Q14 deletion load and size both contribute to refine prognosis in chronic lymphocytic leukemia (CLL). "

M. Martelli (2011) "A RANDOMIZED MULTICENTRE PHASE III STUDY FOR FIRST LINE TREATMENT OF YOUNG PATIENTS WITH HIGH RISK (AAIPI 2-3) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): RITUXIMAB (R) PLUS DOSE-DENSE CHEMOTHERAPY CHOP14/MEGACHOP14 WITH OR WITHOUT INTENSIFIED HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT). RESULTS OF DLCL04 TRIAL OF ITALIAN LYMPHOMA FOUNDATION (FIL)"

F Mauro, R Foà (2011) "A RETROSPECTIVE MULTICENTER TRIAL WITH LOW-DOSE ALEMTUZUMAB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. ON BEHALF OF THE GIMEMA CHRONIC LYMPHOPROLIFERATIVE DISORDERS WORKING PARTY "

F. R. Mauro, A. Guarini, R. Foa (2011) "A phase II study of chlorambucil plus rituximab followed by maintenance versus observation in elderly patients with previously untreated chronic lymphocytic leukemia: Results of the induction phase."

M. Martelli (2011) "ANALYSIS OF PROGNOSTIC FACTORS IN 424 MALT LYMPHOMA PATIENTS TREATED IN THE IELSG-19 MULTICENTER RANDOMISED STUDY"

S Chiaretti, N Peragine, M Marinelli, I Del Giudice (2011) "BCR stimulation induces a differential microRNA (MIR) profiling between B lymphocytes derived from chronic lymphocytic leukemia (CLL) patients and healthy donors. "

Ricciardi M.R., Foà R. (2011) "Combined inhibition of the Bcl-2 and mTOR pathways: in vitro pro-apoptotic effects in Acute Lymphoyd Leukemia."

Mazzucconi MG (2011) "Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP)"

Del Giudice I (2011) "Fludarabine, cyclophosphamide and lenalidomide (FCL) for previously treatd patients with CLL. GIMEMA study CLL0606. "

N Peragine, S Chiaretti, MR Ricciardi, M Marinelli, I Del Giudice (2011) "Genomic and functional analyses of chronic lymphocytic leukemia (CLL) cells following IgD stimulation. "

M. Martelli, R. Foa (2011) "MACOP-B +/- RITUXIMAB FOLLOWED BY INVOLVED MEDIASTINAL RADIOTHERAPY IS A SAFE AND HIGH EFFECTIVE THERAPY FOR PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA (PMBL): LONG TERM RESULTS AND LATE TOXICITY FROM A SINGLE ITALIAN CENTER"

Ilaria Del Giudice (2011) "Mutations of the SF3B1 splicing Factor in Chronic Lymphocytic Leukemia: Association with Progression and Fludarabine-Refractoriness"

M. Martelli (2011) "PET/CT RESPONSE ANALYSIS IN PRIMARY MEDIASTINAL DIFFUSE LARGE B-CELL LYMPHOMA (PMBL): PRELIMINARY RESULTS OF THE IELSG-26 STUDY"

Maria Gabriella Mazzucconi (2011) "PISA post-marketing italian surveillance study on advate treatment of haemophilia A patients in order to evaluate its efficacy, safety and immunogenicity"

M. Martelli (2011) "Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma"

Ricciardi MR (2011) "Potential therapeutic relevance of simultaneous MEK/ERK and mevalonate pathway inhibition in multiple myeloma."

Maria Rosaria Ricciardi, Roberto Foa (2011) "Pre Clinical mTOR-Inhibition of Acute Lymphoblastic Leukemia Cells Synergizes with Pro-Apoptotic Target Therapy Through Mcl-1 Down-Regulation"

I. Del Giudice (2011) "ROLE OF PET/CT IN THE DIAGNOSTIC WORK-UP OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND CLINICAL SIGNS OF DISEASE PROGRESSION/RICHTER’S SYNDROME"

Giuseppe Cimino, Maria Gabriella Mazzucconi, Giuliana Alimena (2011) "Risk Factors for Thrombosis Vary According to Age in Patients with Essential Thrombocythemia: a Retrospective Analysis of 1090 Patients from the "Gruppo Laziale SMPC Ph Negative"

Roberto Foa, Ilaria Del Giudice, Francesca Romana Mauro, Sabina Chiaretti, Anna Guarini (2011) "Rituximab Plus Chlorambucil As Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Pre-Treatment Biological Characteristics and Gene Expression Patterns on Response to Treatment"

F Mauro, R Foà (2011) "THE COEXISTENCE OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MYELOPROLIFERATIVE NEOPLASMS. A RETROSPECTIVE MULTICENTRIC GIMEMA EXPERIENCE"

Mazzucconi MG (2011) "Thrombosis History and Relationship with Low Thrombocytosis, Leukocytosis, and Jak2 V617F Mutation In A Cohort of 977 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia(RIT)"

Ricciardi M.R., Foà R. (2011) "and Bcl-2 Combined Inhibition: Synergistic Effects in Acute Lymphoblastic Leukemia Cells on Proliferation and Apoptosis, Through Mcl-1 Down-regulation."